Egalet Corp – Egalet Corporation 16,666,667 Shares of Common Stock Warrants to Purchase 16,666,667 Shares of Common Stock UNDERWRITING AGREEMENT July 6, 2017 (July 11th, 2017)
Egalet Corporation, a Delaware corporation (the Company), proposes to issue and sell to the several underwriters named in Schedule I hereto (the Underwriters), for whom Cantor Fitzgerald & Co. (CF&CO or the Representative) is acting as representative, (i) an aggregate of 16,666,667 shares (the Firm Shares) of the common stock, par value $0.001 per share, of the Company (Common Stock), and (ii) 16,666,667 warrants to purchase an aggregate of 16,666,667 shares of Common Stock (the Firm Warrants) in the form, and with the terms described in the Prospectus (as defined below), which will be issued pursuant to the Warrant Agreement, to be dated as of the Closing Date (as defined below), between the Company and Broadridge Corporate Issuer Solutions, Inc., acting as warrant agent (the Warrant Agreement), all of which are to be issued and sold by the Company. Each Firm Share is being sold together with a Firm Warrant to purchase one share of Common Stock at an exercise price of $2.70. In additi
Egalet Corp – Drug Product Manufacturing Services Agreement (May 10th, 2017)
THIS DRUG PRODUCT MANUFACTURING SERVICES AGREEMENT (this "Agreement") is effective as of February 28, 2017 (the "Effective Date") by and between Halo Pharmaceutical, Inc., a Delaware corporation, having offices at 30 North Jefferson Road, Whippany, NJ 07981 ("Halo"), and Egalet Corporation, a Delaware corporation, having offices at 600 East Lee Road Suite 100 Wayne, PA 19087, Egalet, Ltd, a UK company having offices at 160 Queen Victoria Street London EC4V 4QQ and Egalet US Inc., having offices at 600 Lee Road, Wayne, PA 19087 (collectively known as "Client").
Egalet Corp – EGALET CORPORATION, as Issuer, the Guarantors Party Hereto as of the Date Hereof and Any Guarantor That Becomes Party Hereto Pursuant to Section 4.10 Hereof 13% Senior Secured Notes (September 1st, 2016)
INDENTURE dated as of August 31, 2016 among Egalet Corporation, a Delaware corporation with an address at 600 Lee Road, Suite 100, Wayne, Pennsylvania 19087 (the Issuer), the Guarantors party hereto as of the date hereof, any other Guarantor that becomes party hereto pursuant to Section 4.10, and U.S. Bank National Association, as trustee (as more fully defined in Section 1.01, the Trustee) and as collateral agent (as more fully defined in Section 1.01, the Collateral Agent).
Egalet Corp – Collateral Agreement Dated as of August 31, 2016 Among (September 1st, 2016)
THIS COLLATERAL AGREEMENT (as amended, extended, renewed, restated, supplemented, waived or otherwise modified from time to time, this Agreement) is entered into as of August 31, 2016, by and among EGALET CORPORATION, a Delaware corporation with an address at 600 Lee Road, Suite 100, Wayne, Pennsylvania 19087 (the Issuer), EGALET US INC., a Delaware corporation (Egalet US), EGALET LIMITED, a private limited company formed under the law of England and Wales (Egalet UK), the other SUBSIDIARY PARTIES (as defined below) from time to time party hereto, U.S. BANK NATIONAL ASSOCIATION, in its capacity as Trustee (and its successors under the Indenture (as defined below), in such capacity, the Trustee), and U.S. BANK NATIONAL ASSOCIATION, in its capacity as collateral agent for the Secured Parties (as defined below) (and its successors under the Indenture, in such capacity, the Collateral Agent).